Pfizer Plans to Submit EUA Application for its COVID-19 Vaccine in Late November
Pfizer CEO Albert Bourla, DVM, PhD, posted a letter on the company’s website noting that the Pfizer/BioNTech COVID-19 vaccine should be ready to apply for the United States Food and Drug Administration’s (FDA) Emergency Use Authorization…